Published • loading... • Updated
AstraZeneca Reveals Clinical Trial Approval Submission Process… "Statistical Developers Responsible for Clinical Data Reliability"
Summary by ddaily.co.kr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
[Grapevine, USA = Digital Daily Reporter Lee Sang-il] A statistical programming expert from global pharmaceutical company AstraZeneca revealed the key role SAS plays in the process of converting clinical trial data into regulatory submission documents. At ‘SAS Innovate 2026,’ held in Grapevine, Texas, from April 27 to 30 (local time), Sampath Madanu, Associate Director of Statistical Programming at AstraZeneca, discussed the process by which cl…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
